Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Common Equity (2016 - 2025)

Innoviva (INVA) has disclosed Common Equity for 16 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 69.69% year-over-year to $1.2 billion, compared with a TTM value of $1.2 billion through Dec 2025, up 69.69%, and an annual FY2025 reading of $1.2 billion, up 69.69% over the prior year.
  • Common Equity was $1.2 billion for Q4 2025 at Innoviva, up from $1.0 billion in the prior quarter.
  • Across five years, Common Equity topped out at $1.2 billion in Q4 2025 and bottomed at $393.7 million in Q2 2021.
  • Average Common Equity over 5 years is $656.3 million, with a median of $644.1 million recorded in 2022.
  • The sharpest move saw Common Equity surged 71.65% in 2021, then dropped 20.74% in 2022.
  • Year by year, Common Equity stood at $525.9 million in 2021, then rose by 7.58% to $565.8 million in 2022, then grew by 19.29% to $675.0 million in 2023, then increased by 2.4% to $691.2 million in 2024, then skyrocketed by 69.69% to $1.2 billion in 2025.
  • Business Quant data shows Common Equity for INVA at $1.2 billion in Q4 2025, $1.0 billion in Q3 2025, and $714.8 million in Q2 2025.